Sponsor:
Robert W Alexander, MD
Code:
NCT03090672
Conditions
Osteoarthritis
Rheumatoid Nodule
Degenerative Joint Disease
Tendinopathy
Tendinosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Normal Saline
Tissue Stromal Vascular Fraction
Platelet Rich Plasma
Cellular Stromal Vascular Fraction
Brief summary:
Conditions
Osteoarthritis
Rheumatoid Nodule
Degenerative Joint Disease
Tendinopathy
Tendinosis
Study ID
NCT03090672
Start date
Mar 11, 2017
Status verified date
Jan, 2020
Completion date
Dec 31, 2022
Anticipated
Primary completion date
Aug 31, 2021
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: tSVF + PRP Arm1
experimental: tSVF + PRP + cSVF Enrichment Arm 2
experimental: Normal Saline IV + cSVF Arm 3
Interventions
Normal Saline
Tissue Stromal Vascular Fraction
Platelet Rich Plasma
Cellular Stromal Vascular Fraction
Primary outcome measure
Central contacts
Locations
Regeneris Medical
Recruiting
North Attleboro, Massachusetts, United States, 02760
Contacts
Regeneris Medical
Recruiting
North Attleboro, Massachusetts, United States, 02760
Contacts
Principal Investigator:
Glenn C Terry, MD
Sponsor
Robert W Alexander, MD
Last update posted
Jan 18, 2020
Last verified
Jan, 2020
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Robert W Alexander, MD on 2020-01-18.